Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma
Brian K. Link, Zuhair K. Ballas, Daniel Weisdorf, James E. Wooldridge, Aaron D. Bossler, Mary Shannon, Wendy L. Rasmussen, Arthur M. Krieg, George J. Weiner
Dive into the research topics of 'Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma'. Together they form a unique fingerprint.